Trial intelligence / Profile preview

Adipose-derived stem cells for chronic non-healing ulcers

PACTR201709002519185Recruiting

Sponsor
Assiut University Hospitals
Start
Sep 2017
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Open-label trial of adipose derived mesenchymal stromal cells in chronic ulcer (2 arms), sponsored by Assiut University Hospitals. Primary endpoint: Primary efficacy endpoint. Started Sep 2017; status: recruiting.

02

Drugs

adipose derived mesenchymal stromal cells
03

Conditions

chronic ulcer

Beyond the preview

Go deeper on PACTR201709002519185.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201709002519185.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call